Literature DB >> 3071067

Free insulin concentrations in immediately extracted plasma samples and their relationships to clinical and metabolic parameters in insulin-treated diabetic patients.

R Giannarelli1, P Marchetti, M Giannecchini, G Di Cianni, P Cecchetti, A Masoni, R Navalesi.   

Abstract

The relationships between free insulin and various clinical and metabolic parameters in insulin-treated diabetic patients are still not clear, possibly because of the technical difficulties in measuring free insulin. Recently, it has been demonstrated that in the presence of insulin antibodies only immediate centrifugation of blood and extraction of insulin antibodies provide an accurate evaluation of in vivo free insulin concentrations. In this study we evaluated the relationships between free and bound insulin levels, insulin antibodies, metabolic control and insulin requirement in 38 insulin-treated diabetic patients, in whom plasma free insulin was assayed in immediately processed samples. The main findings of our study are as follows. Free insulin concentrations ranged from 2.5 to 54 microU/ml; no difference was found between males and females; the unbound hormone level was inversely correlated to fasting plasma glucose (p less than 0.01) and HbA1c (p less than 0.02); a positive correlation was shown between free insulin and daily insulin dose; finally, free insulin concentrations were not correlated with insulin antibody binding.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3071067     DOI: 10.1007/bf02624821

Source DB:  PubMed          Journal:  Acta Diabetol Lat        ISSN: 0001-5563


  22 in total

1.  A simple method for the determination of serum free insulin levels in insulin-treated patients.

Authors:  S Nakagawa; H Nakayama; T Sasaki; K Yoshino; Y Y Yu
Journal:  Diabetes       Date:  1973-08       Impact factor: 9.461

2.  Vascular reflexes in diabetic autonomic neuropathy.

Authors:  D J Ewing; I W Campbell; A A Burt; B F Clarke
Journal:  Lancet       Date:  1973-12-15       Impact factor: 79.321

3.  Comparison of plasma glucose and plasma free insulin during CSII and intensified conventional insulin therapy.

Authors:  M Buysschaert; E Marchand; J M Ketelslegers; A E Lambert
Journal:  Diabetes Care       Date:  1983 Jan-Feb       Impact factor: 19.112

4.  Equilibrium binding assay and kinetic characterization of insulin antibodies.

Authors:  J Goldman; D Baldwin; W Pugh; A H Rubenstein
Journal:  Diabetes       Date:  1978-06       Impact factor: 9.461

Review 5.  Insulin pharmacokinetics.

Authors:  C Binder; T Lauritzen; O Faber; S Pramming
Journal:  Diabetes Care       Date:  1984 Mar-Apr       Impact factor: 19.112

6.  Determination of free and total insulin and C-peptide in insulin-treated diabetics.

Authors:  H Kuzuya; P M Blix; D L Horwitz; D F Steiner; A H Rubenstein
Journal:  Diabetes       Date:  1977-01       Impact factor: 9.461

7.  The effect of immediate polyethylene glycol precipitation on free insulin measurements in diabetic patients with insulin antibodies.

Authors:  R Rudkowski; G Antony
Journal:  Diabetes       Date:  1986-03       Impact factor: 9.461

8.  Relative roles of insulin clearance and insulin sensitivity in the prebreakfast increase in insulin requirements in insulin-dependent diabetic patients.

Authors:  D A Skor; N H White; L Thomas; J V Santiago
Journal:  Diabetes       Date:  1984-01       Impact factor: 9.461

9.  The bioavailability of circulating antibody-bound insulin following insulin withdrawal in Type 1 (insulin-dependent) diabetes.

Authors:  N J Vaughan; J A Matthews; A B Kurtz; J D Nabarro
Journal:  Diabetologia       Date:  1983-05       Impact factor: 10.122

10.  Insulin-I131 metabolism in human subjects: demonstration of insulin binding globulin in the circulation of insulin treated subjects.

Authors:  S A BERSON; R S YALOW; A BAUMAN; M A ROTHSCHILD; K NEWERLY
Journal:  J Clin Invest       Date:  1956-02       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.